Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Millipore and US-based specialty materials company Rohm and Haas have signed a joint development agreement to create new high-performance chromatography products that are used to manufacture biologic drugs.
Subscribe to our email newsletter
Under the terms of the agreement, Millipore’s bioprocess division and Rohm and Haas Ion Exchange Resins will develop improved ion exchange chromatography products for manufacturing biologic drugs. Millipore will gain exclusive access to new, customized chromatography media developed under the agreement.
Ion exchange is used to separate molecules based on their molecular charge and is a critical step in purifying biologic drugs.
Jean-Paul Mangeolle, president of bioprocess division, Millipore, said: “These new ion exchange offerings will build on our strong position in Protein Affinity chromatography and take us a step closer to providing complete, integrated solutions for our biopharmaceutical customers.”